Iovance Biotherapeutics (0JDK.LSE) Q3 2024 Earnings

Aug 8Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.45
-0.41
-0.38
-0.34

Details

Expected EPS
-0.353467
Actual EPS
-0.34
Surprise EPS
0.01
Surprise Percent
+3.81%

Description

⁨Iovance Biotherapeutics⁩ (⁦0JDK.LSE⁩) has reported earnings of ⁦-0.34⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts